Clearpoint Neuro Inc Receivables Turnover Ratio (CLPT), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Clearpoint Neuro Inc   (NASDAQ: CLPT)
 

Clearpoint Neuro Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Clearpoint Neuro Inc 's ability to collect accounts receivable sequentially worsen to 6.92, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Clearpoint Neuro Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 53 days, from 46 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 209 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 1347 to 1709.

What is Receivable Turnover Ratio?
What is Clearpoint Neuro Inc Selling?


What is Receivable Turnover Ratio?





CLPT Receivables Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Receivable Change 137.25 % 38.96 % 3.23 % 22.59 % 45.4 %
Y / Y Revenue Change 42.93 % 33.96 % 9.1 % 17.27 % 11.07 %
Receivable Turnover Ratio (TTM) 6.92 8.01 8.26 8.14 8.21
CLPT's Total Ranking # 1709 # 1347 # 1437 # 1188 # 810
Accounts Receivable average collection period days 53 46 44 45 44
Seq. Receivable Change 32.26 % 63.73 % -6.1 % 16.68 % -22.53 %
Seq. Revenue Change 16.5 % 17.48 % -3.84 % 8.6 % 9.19 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 73
Healthcare Sector # 210
Overall Market # 1709

Receivable Turnover Ratio Statistics
High Average Low
10.76 7.97 4.86
(Dec 31 2017)   (Jun 30 2016)






Financial Statements
Clearpoint Neuro Inc 's Accounts Receivable $ 9 Millions Visit CLPT's Balance sheet
Clearpoint Neuro Inc 's Sales TTM $ 41 Millions Visit CLPT's Income Statement
Sources of CLPT's Revenues Visit CLPT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CLPT's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CLPT's Growth Rates CLPT's Roa CLPT's Inventory Turnover Ratio CLPT's Dividend Comparisons
CLPT's Profitability Ratios CLPT's Roi CLPT's Asset Turnover Ratio CLPT's Dividend Growth
CLPT's Valuation Ratios CLPT's Roe CLPT's Financial Strength Ratios CLPT's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026
Lifestance Health Group Inc   12.74 $ 1,494.791  Millions$ 117.296  Millions
Chemed Corporation  12.73 $ 2,540.548  Millions$ 199.626  Millions
Milestone Scientific Inc   12.69 $ 8.337  Millions$ 0.657  Millions
Lftd Partners Inc   12.55 $ 36.955  Millions$ 2.945  Millions
Clene Inc   12.47 $ 0.134  Millions$ 0.011  Millions
Skinhealth Systems Inc   12.27 $ 295.223  Millions$ 24.052  Millions
Cytokinetics Incorporated  12.16 $ 105.815  Millions$ 8.702  Millions
Precision Biosciences Inc  11.94 $ 45.073  Millions$ 3.776  Millions
Teladoc Health Inc   11.94 $ 2,514.453  Millions$ 210.660  Millions
Option Care Health Inc   11.65 $ 5,666.577  Millions$ 486.439  Millions
Ensysce Biosciences Inc   11.55 $ 4.708  Millions$ 0.407  Millions
Crinetics Pharmaceuticals Inc   11.52 $ 18.069  Millions$ 1.569  Millions
Icu Medical Inc  11.46 $ 2,156.379  Millions$ 188.157  Millions
Nrc Health  11.42 $ 138.642  Millions$ 12.138  Millions
Nuvation Bio Inc   11.41 $ 142.121  Millions$ 12.454  Millions
Integrated Biopharma Inc  11.34 $ 47.241  Millions$ 4.165  Millions
National Healthcare Corp  11.07 $ 1,525.905  Millions$ 137.813  Millions
Vireo Growth Inc.  11.01 $ 350.469  Millions$ 31.834  Millions
Bioaffinity Technologies Inc   10.79 $ 5.660  Millions$ 0.525  Millions
Vivos Therapeutics Inc   10.73 $ 19.092  Millions$ 1.779  Millions
Veracyte Inc   10.68 $ 516.183  Millions$ 48.353  Millions
Immucell Corporation  10.51 $ 29.035  Millions$ 2.762  Millions
Kestra Medical Technologies Ltd   10.51 $ 93.819  Millions$ 8.925  Millions
Lifeloc Technologies Inc   10.41 $ 9.044  Millions$ 0.869  Millions
Monte Rosa Therapeutics Inc   10.39 $ 42.953  Millions$ 4.136  Millions
International Stem Cell Corporation  10.23 $ 9.286  Millions$ 0.908  Millions
Pavmed Inc   10.19 $ 0.107  Millions$ 0.011  Millions
Viemed Healthcare Inc   10.16 $ 286.565  Millions$ 28.217  Millions
Addus Homecare Corp  10.14 $ 1,447.070  Millions$ 142.667  Millions
Utah Medical Products Inc  10.13 $ 36.745  Millions$ 3.629  Millions

Date modified: 2026-08-29T17:30:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.